1. Academic Validation
  2. Synthesis and in vitro cytotoxic evaluation of new 1H-benzo[d]imidazole derivatives of dehydroabietic acid

Synthesis and in vitro cytotoxic evaluation of new 1H-benzo[d]imidazole derivatives of dehydroabietic acid

  • Bioorg Med Chem Lett. 2017 Mar 1;27(5):1296-1300. doi: 10.1016/j.bmcl.2017.01.028.
Wen Gu 1 Ting-Ting Miao 2 Da-Wei Hua 2 Xiao-Yan Jin 2 Xu-Bing Tao 2 Chao-Bo Huang 2 Shi-Fa Wang 2
Affiliations

Affiliations

  • 1 Jiangsu Key Lab of Biomass-based Green Fuels and Chemicals, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, PR China. Electronic address: njguwen@163.com.
  • 2 Jiangsu Key Lab of Biomass-based Green Fuels and Chemicals, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, PR China.
Abstract

A series of new 1H-benzo[d]imidazole derivatives of dehydroabietic acid were designed and synthesized as potent antitumor agents. Structures of the target molecules were characterized using MS, IR, 1H NMR, 13C NMR and elemental analyses. In the in vitro cytotoxic assay, most compounds showed significant cytotoxic activities against two hepatocarcinoma cells (SMMC-7721 and HepG2) and reduced cytotoxicity against noncancerous human hepatocyte (LO2). Among them, compound 7b exhibited the best cytotoxicity against SMMC-7721 cells (IC50: 0.36±0.13μM), while 7e was most potent to HepG2 cells (IC50: 0.12±0.03μM). The cell cycle analysis indicated that compound 7b caused cell cycle arrest of SMMC-7721 cells at G2/M phase. Further, compound 7b also induced the Apoptosis of SMMC-7721 cells in Annexin V-APC/7-AAD binding assay.

Keywords

Apoptosis; Benzimidazole; Cytotoxic activity; Dehydroabietic acid; Schiff base.

Figures